Applying Decision Analysis to Management of Adolescent Idiopathic Nephrotic Syndrome

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 1994 Dec 1

PMID 7696099

Citations 4

Authors

F B Stapleton

L G Feld

Affiliations

Soon will be listed here.

Abstract

Due to the concern that adolescents presenting with nephrotic syndrome are less likely to have minimal change disease than younger children, pediatric nephrologists have tended toward renal biopsy-tailored treatment rather than corticosteroid use in this population. The need for biopsy prior to treatment of nephrotic syndrome in adults has been challenged. A similar challenge to the clinical need for this procedure in adolescents with idiopathic nephrotic syndrome is raised here. The principles of medical decision analysis were applied and calculations were made with the Decision Maker computer program. The life expectancy of an adolescent who receives biopsy-tailored treatment was found to be no different from that of an adolescent who receives empiric corticosteroid treatment. We conclude that renal biopsy is not mandatory for the clinical management of adolescents with idiopathic nephrotic syndrome. Prognostically, a response, or lack thereof, to empiric corticosteroid therapy may be just as informative as a histological diagnosis.

Citing Articles

Clinical and Histopathologic Characteristics of Pediatric Patients With Primary Membranous Nephropathy.

Kouri A, Caza T, Beck Jr L, Misurac J, Evans M, Phillips C Kidney Int Rep. 2023; 8(11):2368-2375.

PMID: 38025223 PMC: 10658230. DOI: 10.1016/j.ekir.2023.08.018.

Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.

Safar-Boueri L, Piya A, Beck Jr L, Ayalon R Pediatr Nephrol. 2019; 36(1):19-30.

PMID: 31811540 DOI: 10.1007/s00467-019-04425-1.

Membranous nephropathy: not just a disease for adults.

Ayalon R, Beck Jr L Pediatr Nephrol. 2013; 30(1):31-9.

PMID: 24375012 PMC: 4074564. DOI: 10.1007/s00467-013-2717-z.

Membranous nephropathy in children: clinical presentation and therapeutic approach.

Menon S, Valentini R Pediatr Nephrol. 2009; 25(8):1419-28.

PMID: 19908069 PMC: 2887508. DOI: 10.1007/s00467-009-1324-5.

References

Kassirer J . The principles of clinical decision making: an introduction to decision analysis. Yale J Biol Med. 1976; 49(2):149-64. PMC: 2595272. View

Pauker S . Coronary artery surgery: the use of decision analysis. Ann Intern Med. 1976; 85(1):8-18. DOI: 10.7326/0003-4819-85-1-8. View

. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med. 1979; 301(24):1301-6. DOI: 10.1056/NEJM197912133012401. View

Evans R, Manninen D, Garrison Jr L, HART L, Blagg C, Gutman R . The quality of life of patients with end-stage renal disease. N Engl J Med. 1985; 312(9):553-9. DOI: 10.1056/NEJM198502283120905. View

Gorry G, Kassirer J, Essig A, SCHWARTZ W . Decision analysis as the basis for computer-aided management of acute renal failure. Am J Med. 1973; 55(3):473-84. DOI: 10.1016/0002-9343(73)90204-0. View

Madaio M . Renal biopsy. Kidney Int. 1990; 38(3):529-43. DOI: 10.1038/ki.1990.236. View

Glassock R . Treatment of immunologically mediated glomerular disease. Kidney Int Suppl. 1992; 38:S121-6. View

Levey A, Lau J, Pauker S, Kassirer J . Idiopathic nephrotic syndrome. Puncturing the biopsy myth. Ann Intern Med. 1987; 107(5):697-713. DOI: 10.7326/0003-4819-107-5-697. View

Lau J, Levey A, Kassirer J, Pauker S . Idiopathic nephrotic syndrome in a 53-year-old woman. Is a kidney biopsy necessary?. Med Decis Making. 1982; 2(4):497-519. DOI: 10.1177/0272989X8200200413. View

10.

Kassirer J . Is renal biopsy necessary for optimal management of the idiopathic nephrotic syndrome?. Kidney Int. 1983; 24(4):561-75. DOI: 10.1038/ki.1983.194. View

11.

McEnery P, McADAMS A, WEST C . The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine (Baltimore). 1985; 64(6):401-24. DOI: 10.1097/00005792-198511000-00005. View

12.

Tarshish P, Bernstein J, Tobin J, EDELMANN Jr C . Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children. Pediatr Nephrol. 1992; 6(2):123-30. DOI: 10.1007/BF00866289. View

13.

Pauker S, Kassirer J . Decision analysis. N Engl J Med. 1987; 316(5):250-8. DOI: 10.1056/NEJM198701293160505. View

14.

WEST C . Idiopathic membranoproliferative glomerulonephritis in childhood. Pediatr Nephrol. 1992; 6(1):96-103. DOI: 10.1007/BF00856851. View

15.

Lau J, Kassirer J, Pauker S . Decision Maker 3.0. Improved decision analysis by personal computer. Med Decis Making. 1983; 3(1):39-43. DOI: 10.1177/0272989X8300300110. View

16.

Chesney R, NOVELLO A . Forms of nephrotic syndrome more likely to progress to renal impairment. Pediatr Clin North Am. 1987; 34(3):609-27. DOI: 10.1016/s0031-3955(16)36253-8. View

17.

Collan Y, Klockars M, Heino M . Revision of light-microscopic kidney biopsy diagnosis in glomerular disease. Nephron. 1978; 20(1):24-31. DOI: 10.1159/000181192. View

18.

Johnson J, McCauley C, Copley J . The quality of life of hemodialysis and transplant patients. Kidney Int. 1982; 22(3):286-91. DOI: 10.1038/ki.1982.167. View

19.

Magid D, Schwartz B, Craft J, Schwartz J . Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med. 1992; 327(8):534-41. DOI: 10.1056/NEJM199208203270806. View

20.

Safran C, Tsichlis P, Bluming A, DESFORGES J . Diagnostic planning using computer assisted decision-making for patients with Hodgkin's disease. Cancer. 1977; 39(6):2426-34. DOI: 10.1002/1097-0142(197706)39:6<2426::aid-cncr2820390619>3.0.co;2-f. View